Literature DB >> 10400255

Methodological approaches for assessing response shift in longitudinal health-related quality-of-life research.

C E Schwartz1, M A Sprangers.   

Abstract

The impact of health state changes on an individual's quality of life (QOL) has gained increased attention in social and medical clinical research. An emerging construct of relevance to this line of investigation is response shift phenomenon. This construct refers to the changes in internal standards, in values, or in the conceptualization of QOL which are catalyzed by health state changes. In an effort to stimulate research on response shift, we present methodological considerations and promising assessment approaches for measuring it in observational and interventional clinical research. We describe and evaluate individualized methods, preference-based methods, successive comparison methods, design approaches, statistical approaches and qualitative approaches. The hierarchical structure of the construct is also discussed, with particular emphasis on how it might be elucidated by empirical assessment which uses the proposed methods and approaches. It is also recommended that criterion measures of change be included in future studies of response shift.

Mesh:

Year:  1999        PMID: 10400255     DOI: 10.1016/s0277-9536(99)00047-7

Source DB:  PubMed          Journal:  Soc Sci Med        ISSN: 0277-9536            Impact factor:   4.634


  219 in total

1.  The impact of herpes zoster and postherpetic neuralgia on health-related quality of life: a prospective study.

Authors:  Mélanie Drolet; Marc Brisson; Kenneth E Schmader; Myron J Levin; Robert Johnson; Michael N Oxman; David Patrick; Caty Blanchette; James A Mansi
Journal:  CMAJ       Date:  2010-10-04       Impact factor: 8.262

2.  Hi! How are you? Response shift, implicit theories and differing epistemologies.

Authors:  Geoffrey Norman
Journal:  Qual Life Res       Date:  2003-05       Impact factor: 4.147

3.  Development and initial validation of a new preference-based disease-specific health-related quality of life instrument for erectile function.

Authors:  G W Torrance; M A Keresteci; R W Casey; A J Rosner; N Ryan; M C Breton
Journal:  Qual Life Res       Date:  2004-03       Impact factor: 4.147

4.  Quantitative assessment of changes in patients' constructs of quality of life: an application of multilevel models.

Authors:  Adam Lowy; Jürg Bernhard
Journal:  Qual Life Res       Date:  2004-09       Impact factor: 4.147

5.  Response shift effects on measuring post-operative quality of life among breast cancer patients: a multicenter cohort study.

Authors:  T S Dabakuyo; F Guillemin; T Conroy; M Velten; D Jolly; M Mercier; S Causeret; J Cuisenier; O Graesslin; M Gauthier; F Bonnetain
Journal:  Qual Life Res       Date:  2012-03-01       Impact factor: 4.147

6.  Abandoning the language of "response shift": a plea for conceptual clarity in distinguishing scale recalibration from true changes in quality of life.

Authors:  Peter A Ubel; Yvette Peeters; Dylan Smith
Journal:  Qual Life Res       Date:  2010-01-29       Impact factor: 4.147

7.  In reply to: Association between utility and treatment among patients with prostate cancer.

Authors:  Pranav Gandhi; Joshua Spooner; I-Chan Huang
Journal:  Qual Life Res       Date:  2010-06-26       Impact factor: 4.147

8.  On the validity of measuring change over time in routine clinical assessment: a close examination of item-level response shifts in psychosomatic inpatients.

Authors:  S Nolte; A Mierke; H F Fischer; M Rose
Journal:  Qual Life Res       Date:  2015-09-09       Impact factor: 4.147

9.  Whose quality of life? A commentary exploring discrepancies between health state evaluations of patients and the general public.

Authors:  Peter A Ubel; George Loewenstein; Christopher Jepson
Journal:  Qual Life Res       Date:  2003-09       Impact factor: 4.147

10.  Influence of explanatory and confounding variables on HRQoL after controlling for measurement bias and response shift in measurement.

Authors:  Pranav K Gandhi; L Douglas Ried; Carole L Kimberlin; Teresa L Kauf; I-Chan Huang
Journal:  Expert Rev Pharmacoecon Outcomes Res       Date:  2013-12       Impact factor: 2.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.